Obligacje
Poniżej znajduje się lista obligacji korporacyjnych Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 5,75% | 0 | 54,74% | 1,625% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. | |
| 5,65% | 44 K | 88,40% | 4,650% | 2044-06-15 | 38,34 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,53% | 0 | 78,99% | 4,150% | 2059-03-15 | 591,29 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,52% | 772 K | 102,00% | 5,650% | 2065-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,50% | 3,94 M | 95,16% | 5,200% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,50% | 576 K | 93,65% | 5,100% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,49% | 11,14 M | 101,70% | 5,600% | 2065-02-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,48% | 990 K | 91,61% | 4,950% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 0 | 80,48% | 3,950% | 2049-03-15 | 958,15 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 0 | 57,23% | 2,250% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,42% | 149 K | 93,85% | 5,000% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,42% | 1,11 M | 101,80% | 5,550% | 2055-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,42% | 3,32 M | 92,26% | 4,875% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,41% | 319 K | 94,72% | 5,050% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,40% | 5,72 M | 101,37% | 5,500% | 2055-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,35% | 0 | 55,17% | 2,500% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,34% | 1,4 M | 82,30% | 3,950% | 2047-05-15 | 346,95 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,29% | 30 K | 80,91% | 3,700% | 2045-03-01 | 386,8 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,28% | 0 | 86,68% | 3,875% | 2039-03-15 | 240,25 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,01% | 4 K | 113,94% | 6,770% | 2036-01-01 | 158,56 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. | |
| 4,69% | 15 K | 111,44% | 5,950% | 2037-11-15 | 266,83 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,64% | 8,94 M | 102,01% | 4,900% | 2035-10-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,61% | 2,57 M | 103,60% | 5,100% | 2035-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,60% | 15 K | 108,32% | 5,550% | 2037-03-15 | 444,73 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,59% | 1,95 M | 100,09% | 5,000% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,50% | 632 K | 100,74% | 4,600% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,40% | 0 | 45,92% | 1,375% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,32% | 2,02 M | 102,32% | 4,700% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,31% | 997 K | 102,66% | 4,700% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,29% | 373 K | 101,48% | 4,550% | 2032-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,16% | 179 K | 104,02% | 4,900% | 2032-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,12% | 1,17 M | 100,60% | 4,250% | 2031-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,08% | 0 | 53,38% | 1,125% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,06% | 0 | 64,27% | 1,700% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,00% | 38,56 M | 102,85% | 4,750% | 2030-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,94% | 0 | 98,27% | 3,375% | 2029-03-15 | 930,56 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,90% | 1,41 M | 101,02% | 4,200% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,87% | 643 K | 101,88% | 4,500% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,86% | 230 K | 98,95% | 3,100% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,82% | 402 K | 100,80% | 4,500% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,78% | 4,23 M | 100,57% | 4,000% | 2028-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,73% | 357 K | 100,70% | 4,150% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,71% | 220 K | 101,76% | 4,550% | 2028-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,70% | 174 K | 102,29% | 5,500% | 2027-03-15 | 364,32 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,09% | 0 | 82,25% | 0,500% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,91% | 0 | 87,71% | 0,625% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,78% | 0 | 97,23% | 2,125% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,21% | 0 | 99,69% | 1,625% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 0,51% | 0 | 99,85% | 0,450% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. | |
| — | 250 K | 100,70% | 4,767% | 2028-10-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |